Why did KKUR spike on 03 Jan 2026?

The intraday spike to USD 0.000002 occurred on just 17.00 shares; no public earnings or material news were recorded in the feed, so the move is likely due to isolated trades and thin liquidity rather than company fundamentals.

What is Meyka AI’s rating for KKUR?

Meyka AI rates KKUR with a score out of 100 at 62.75 (Grade B) and issues a HOLD suggestion; the grade factors in benchmark, sector, financial growth, key metrics and analyst consensus.

What are the main risks with KKUR stock?

Primary risks are extreme illiquidity, limited public financial data, near-zero pricing that inflates percentage moves, and lack of analyst coverage; these increase volatility and execution risk for traders and investors.

Does Meyka AI provide a price forecast for KKUR?

Yes, Meyka AI's forecast model projects a base-case short-term price of USD 0.000002, implying 100.00% upside versus the current USD 0.000001, but forecasts are model-based projections and not guarantees.

US Stocks

ChromoCure (KKUR) trades at $0.000001 on 03 Jan 2026 Market hours: micro-volume gain, assess liquidity risk

ByDanny Kontos January 3, 2026January 3, 2026

KKUR (ChromoCure, Inc.) traded at USD 0.000001 on 03 Jan 2026 during market hours on the PNK exchange, marking a micro-volume gain that pushed the day high to USD 0.000002. KKUR stock moved on just 17 shares versus an average daily volume of 2,900,052.00 shares, so price swings reflect extremely thin liquidity rather than broad investor demand. We review what caused the spike, the balance of upside versus liquidity risk, and how the move fits sector trends in Healthcare